EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Knowledge and Practice in Reversal of Oral Anticoagulation Therapy among Government Healthcare Professionals in Malaysia: A Nationwide Survey

Sze Ling Tan, Chelfi Zhi Fei Chua, Jagan Nirmala, Sim Mei Chuah, Mohamed Sahimi

Journal of Asian Pacific Society of Cardiology · 10.08.2026

DOI: 10.15420/japsc.2025.109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Asian Pacific Society of Cardiology, online erschienen am 10.08.2026. Verfasst von Sze Ling Tan und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The rising use of oral anticoagulants (OACs) necessitates effective and timely reversal strategies. Despite established recommendations, variability remains in the prescribing and usage of OAC reversal agents. This study aimed to assess the availability of reversal agents and evaluate the practice and knowledge of healthcare professionals (HCPs) in managing OAC reversal within Ministry of Health Malaysia hospitals.

Methods

A cross-sectional, self-administered questionnaire was distributed to prescribers and pharmacists across state, major specialist and minor specialist hospitals between October 2024 and March 2025. Descriptive analyses were used to analyse responses.

Results

A total of 473 prescribers and 943 pharmacists from 64 hospitals participated. Injection phytomenadione was available in all facilities; 58 hospitals (90.6%) stocked fresh frozen plasma, and approximately 80% reported access to four-factor prothrombin complex concentrate (4F-PCC). Only two hospitals had an institutional OAC reversal policy. More than half of respondents correctly identified clinical scenarios for phytomenadione use; however, many selected it as first-line therapy for warfarin-induced life-threatening bleeding. Most respondents preferred 4F-PCC for direct OAC (DOAC) reversal and idarucizumab for dabigatran-related life-threatening bleeding. For urgent procedure reversal, HCPs commonly recommended phytomenadione for warfarin, 4F-PCC for DOACs and idarucizumab for dabigatran. The confidence level of HCPs in managing warfarin reversal was higher than that for DOAC reversal. Most HCPs recognised the advantages of prothrombin complex concentrate over fresh frozen plasma.

Conclusion

Notable gaps remain between knowledge and practice as well as institutional access to recommended reversal agents. Improved availability, standardised protocols and adherence to current evidence-based guidelines are needed to optimise OAC reversal practices.

Zitieren

APA

Tan, S. L., Chua, C. Z. F., Nirmala, J., Chuah, S. M., & Sahimi, M. (2026). Knowledge and Practice in Reversal of Oral Anticoagulation Therapy among Government Healthcare Professionals in Malaysia: A Nationwide Survey. Journal of Asian Pacific Society of Cardiology. https://doi.org/10.15420/japsc.2025.109

Vancouver

Tan SL, Chua CZF, Nirmala J, Chuah SM, Sahimi M. Knowledge and Practice in Reversal of Oral Anticoagulation Therapy among Government Healthcare Professionals in Malaysia: A Nationwide Survey. Journal of Asian Pacific Society of Cardiology. 2026. doi:10.15420/japsc.2025.109

BibTeX
@article{Tan2026,
  author = {Tan, Sze Ling and Chua, Chelfi Zhi Fei and Nirmala, Jagan and Chuah, Sim Mei and Sahimi, Mohamed},
  title = {Knowledge and Practice in Reversal of Oral Anticoagulation Therapy among Government Healthcare Professionals in Malaysia: A Nationwide Survey},
  journal = {Journal of Asian Pacific Society of Cardiology},
  year = {2026},
  doi = {10.15420/japsc.2025.109}
}
Kostenlos starten →